Single-cell sequencing provides unprecedented detail into cell-to-cell variability, uncovering key biological mechanisms in ...
Tech-savvy parents to be are using IVF and screening embryos to build families in ways that were unimaginable a few short years ago.
Across the Bay Area, a growing cohort of founders, investors, and technologists is approaching parenthood in a way that looks ...
Study shows that rare variants captured by Illumina WGS with DRAGENâ„¢ variant calling explain most of the "missing heritability" in complex human diseases and traits, including those related to blood ...
Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...
Illumina's stock has seen a modest increase in its Fair Value Estimate, rising from $113.58 to $117.74. This reflects improved analyst confidence in the company's future prospects. This change comes ...
Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.
A team from the Andalusian Center for Molecular Biology and Regenerative Medicine (CABIMER) has developed an innovative ...
This valuable study presents an analysis of the gene regulatory networks that contribute to tumour heterogeneity and tumor plasticity in Ewing sarcoma, with key implications for other fusion-driven ...